Clinical Trials Directory

Trials / Completed

CompletedNCT00168194

Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History

Status
Completed
Phase
Study type
Observational
Enrollment
104 (actual)
Sponsor
The Alfred · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

It remains unclear why some individuals are able to clear HBV from their bodies while in others HBV is a persistent infection. We plan to investigate this process by collecting blood and analysing how the patient's white blood cells respond to different pieces of the HBV virus. We will use new tools that can precisely tell us which component of the immune response may be different in individuals who are chronically infected with HBV and also in individuals who are also infected with HIV. The primary aims are therefore: 1. To characterize HBV-specific T cell responses in HBV chronic carriers, and identify novel immunogenic regions in both HLA-A2+ and non-HLA-A2+ individuals. 2. To determine the effect of HIV infection on HBV-specific T-cell responses

Conditions

Timeline

Start date
2004-12-01
Completion
2009-12-01
First posted
2005-09-15
Last updated
2012-01-20

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00168194. Inclusion in this directory is not an endorsement.